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Case Report
Osteoclast-Like Giant Cell Carcinoma of the Distal Ureter
Hongzoo Park
Department of Urology, School of Medicine, Kangwon National University, Chuncheon, Korea
Extraskeletal osteoclast-like giant cell (OGC) tumors are uncommon and have mainly 
been found in the breast and pancreas. OGC neoplasms of the urinary tract are ex-
tremely rare. Most cases found in the renal pelvis and bladder are associated with either 
an in situ urothelial malignancy or a conventional high-grade urothelial carcinoma. 
These malignancies tend to be associated with a poor prognosis and disease course. To 
our knowledge, no cases of OGC tumors of the distal ureter only have been published. 
Here, we present the case of a 76-year-old man who underwent hand-assisted laparo-
scopic nephroureterectomy because of painless gross hematuria with right flank pain. 
Pathologic examination showed OGC carcinoma of the right distal ureter. No local tu-
mor recurrence or distant metastasis was found at the 5-month follow-up.
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FIG. 1. Magnetic resonance urography shows an eccentric 
enhanced mural thickening of the right distal ureter 2 cm from
the ureterovesical junction and measuring approximately 5 cm.
Extraskeletal osteoclast-like giant cell (OGC) tumors usu-
ally originate from bone, tendon, sheath, or soft tissue and 
consist of oval, plump mononuclear cells. OGC tumors have 
a slow growth rate and a low incidence of malignant behavior. 
Tumors with similar histologic characteristics have been 
described in a variety of visceral organs, such as the pan-
creas, ovary, larynx, thyroid, and salivary glands [1]. The 
etiology and histogenesis of OGC tumors are controversial 
and have largely remained unexplained. To the best of our 
knowledge, fewer than 30 case reports of OGC tumors of 
the urinary tract have been published in the English liter-
ature [2-6]. The most common tumor locations in the uri-
nary tract are the kidney, renal pelvis, and bladder. Only 
one case of OGC carcinoma of the bladder with right ureter 
invasion has been reported [6]. Here, we report a case of 
OGC carcinoma of the distal ureter without a bladder tumor.
CASE REPORT
A 76-year-old male ex-smoker presented with a recent his-
tory of hematuria and transient right-flank pain. On phys-
ical examination, no mass was palpable in the abdomen, 
and no costovertebral angle tenderness was found. Hemo-
gram and blood chemistry results were normal, except for 
azotemia (serum creatinine, 2.2 ng/ml). Intravenous pye-
lography showed a filling defect of the right distal ureter. 
Magnetic resonance urography confirmed an irregular 
ureter mass 2 cm from the ureterovesical junction of ap-
proximately 5 cm (Fig. 1). No findings suggested lympha-
denopathy or distant metastasis. Cystoscopy showed no Korean J Urol 2011;52:68-70
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FIG. 2. Gross image of the kidney and distal ureter tumor.
FIG. 3. Pathologic examination shows osteoclast-like giant cell 
carcinoma (H&E, x200).
abnormalities in the urinary bladder, and the findings of 
urine cytologic examination were negative.
　Ureteroscopy showed a nodular lesion obstructing the 
distal ureter. A complete right hand-assisted laparoscopic 
nephroureterectomy was performed. Grossly, several small 
and large simple cysts were observed in the renal cortex, 
of which the largest measured 3x2 cm. The pelvis was cysti-
cally dilated and was shown to contain clear fluid. The dis-
tal end area was dilated, and an irregular polypoid mass 
measuring 5x1.5x1.2 cm was identified 2 cm from the blad-
der cuff (Fig. 2). Microscopically, a population of mono-
nuclear cells with numerous interspersed multinucleated 
giant cells were observed. The mononuclear cells contained 
round- to oval-shaped nuclei with vesicular chromatin, in-
conspicuous nucleoli, moderate nuclear clearing, and mild 
nuclear pleomorphism. The cytoplasm was amphophilic, 
and cytoplasmic vacuolation was observed in the focal cells. 
Approximately 2 mitoses per 10 high-power fields were 
observed. OGCs had multiple round-to-oval, bland-ap-
pearing nuclei ranging from 4 to 34 in number. Their cyto-
plasm was eosinophilic and had well-demarcated cellular 
boundaries (Fig. 3). Areas of conventional high-grade ur-
othelial carcinoma were noted adjacent to the tumor. The 
tumor invaded focally into the periureteric adipose tissue 
and was categorized as American Joint Committee on 
Cancer stage pT3NxMx. Immunohistologic examination 
showed that the multinucleated giant cells were positive 
for CD68, CD45, epithelial membrane antigen (EMA), vi-
mentin, and cytokeratin (cytoplasmic but not nuclear 
staining) and negative for desmin and CD31 (Fig. 4). At the 
5-month postsurgical follow-up, the patient was doing well, 
had no evidence of disease recurrence, and had a serum cre-
atinine level of 2.5 ng/ml.
DISCUSSION
Extraskeletal OGC carcinoma of the urinary tract is ex-
tremely rare and has most frequently been reported in the 
breast and pancreas. Fewer than 30 case reports of OGC 
tumors of the urinary tract have been published in the 
English literature [2-6]. The most common tumor locations 
in the urinary tract are the kidney, renal pelvis, and 
bladder. Only one case of OGC carcinoma of the bladder 
with right ureter invasion has been reported [6]. To the best 
of our knowledge, this is the first case report of an OGC car-
cinoma of the distal ureter without a bladder tumor. 
　Much controversy exists regarding the nature and origin 
of epithelial, histiocytic, and mesenchymal OGCs. One 
study indicated that these types of OGCs may result from 
the fusion of mononuclear histiocytes/macrophages, which 
are attracted to the tumor by growth or chemotactic factors 
released by neoplastic epithelial cells [7]. Immunohisto-
chemical analysis in this previous study showed that the 
OGCs were positive for vimentin, EMA, and the cell surface 
proteins CD68 and CD45 and were negative for cytokeratin 
[8]. The prognostic implication of these immunohisto-
chemical results remains unclear. Further investigation is 
needed to improve our understanding of this phenomenon.
　The symptoms of extraskeletal OGC carcinoma in the 
urinary tract are nonspecific. As is well known, hematuria 
and flank pain are the most common and frequent initial 
symptoms [2]. The appearance of OGC carcinoma under 
cystoureteroscopy is similar to that of other urothelial 
tumors. Because of the rarity of OGC tumors in the urinary 
tract, its prognosis is unclear. Previous reports indicate Korean J Urol 2011;52:68-70
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that the median survival rate associated with OGC tumors 
is less than 2 years [2]. Surgery is the treatment of choice. 
Aggressive management is recommended because of the 
poor prognosis of this condition; however, no adjuvant treat-
ment has yet been established. Adjuvant radiation therapy 
may be beneficial, because giant cell tumors of the bone are 
radiosensitive. Although adjuvant chemotherapy, such as 
mitoxantrone/etoposide/cyclosporine, has been reported to 
be beneficial in patients with transitional cell carcinoma 
of the urinary tract, a large population-based study is need-
ed to confirm the benefits of such therapy in the treatment 
of invasive OGC tumors of the urinary tract [8]. Previous 
reports indicate that extensive surgical excision appears 
to be the recommended treatment for primary or recurrent 
lesions until the treatment benefits of adjuvant chemo-
therapy or radiotherapy are established.
Conflicts of Interest
The authors have nothing to disclose.
REFERENCES
1. Silverberg SG, DeGiorgi LS. Osteoclastoma-like giant cell tumor 
of the thyroid. Report of a case with prolonged survival following 
partial excision and radiotherapy. Cancer 1973;31:621-5.
2. Baydar D, Amin MB, Epstein JI. Osteoclast-rich undifferentiated 
carcinomas of the urinary tract. Mod Pathol 2006;19:161-71.
3. Castelino-Prabhu S, Ali SZ. Osteoclast-rich undifferentiated car-
cinoma of the urinary tract: cytologic findings and literature 
review. Diagn Cytopathol 2010;38:364-7.
4. McCash SI, Unger P, Dillon R, Xiao GQ. Undifferentiated carcino-
ma of the renal pelvis with osteoclast-like giant cells: a report of 
two cases. APMIS 2010;118:407-12.
5. O'Connor RC, Hollowell CM, Laven BA, Yang XJ, Steinberg GD, 
Zagaja GP. Recurrent giant cell carcinoma of the bladder. J Urol 
2002;167:1784.
6. Wu PJ, Su CK, Li JR, Yang CR, Chen CL. Osteoclast-like giant 
cell carcinoma of the urinary bladder. J Chin Med Assoc 2009;72: 
495-7.
7. Molberg KH, Heffess C, Delgado R, Albores-Saavedra J. 
Undifferentiated carcinoma with osteoclast-like giant cells of the 
pancreas and periampullary region. Cancer 1998;82:1279-87.
8. Sarnaik AA, Saad AG, Mutema GK, Martin SP, Attar A, Lowy AM. 
Osteoclast-like giant cell tumor of the pancreas associated with 
a mucinous cystadenocarcinoma. Surgery 2003;133:700-1.
FIG. 4. Immunohistologic staining shows that the osteoclast- 
like giant cells were positive for CD68 (A), epithelial mem-
brane antigen (B), and vimentin (C) (H&E, x400).